| Literature DB >> 36187804 |
Zuo Wang1, Lei Yin1, Lei Liu1, Xinyi Lan1, Jianhua He1, Fachun Wan1, Weijun Shen1, Shaoxun Tang2, Zhiliang Tan2, Yanming Yang3.
Abstract
The present study was performed to evaluate the impacts of tannic acid (TA) supplementation at different levels on the growth performance, physiological, oxidative and immunological metrics, and ruminal microflora of Xiangdong black goats. Twenty-four goats were randomly assigned to four dietary treatments: the control (CON, basal diet), the low-dose TA group [TAL, 0.3 % of dry matter (DM)], the mid-dose TA group (TAM, 0.6 % of DM), and the high-dose TA group (TAH, 0.9 % of DM). Results showed that the growth performance was unaffected (P > 0.05) by adding TA, whilst the 0.3 % and 0.6 % TA supplementation significantly decreased (P < 0.05) the apparent digestibility of crude protein (CP) and ruminal NH3-N concentration, and raised (P < 0.05) the level of total volatile fatty acid (TVFA) in rumen. The increments of alanine aminotransferase (ALT), triglyceride (TG), cortisol (CORT), total antioxidant capacity (T-AOC), interleukin (IL)-1β, IL-6, and serumamyloid A (SAA), and decrements of globulin (GLB), immunoglobulin G (IgG), cholinesterase (CHE), glutathione reductase (GR), creatinine (CRE), growth hormone (GH), high-density lipoprotein cholesterol (HDLC), and insulin-like growth factor 1 (IGF-1) to different extents by TA addition were observed. Although the Alpha and Beta diversity of rumen bacterial community remained unchanged by supplementing TA, the relative abundance of the predominant genus Prevotella_1 was significantly enriched (P < 0.05) in TAL. It could hence be concluded that the TA supplementation in the present trial generally decreased CP digestion and caused oxidative stress and inflammatory response without influencing growth performance and ruminal microbiota diversity. More research is needed to explore the premium dosage and mechanisms of effects for TA addition in the diet of goats.Entities:
Keywords: goats; inflammatory response; oxidative stress; ruminal microflora; tannic acid
Year: 2022 PMID: 36187804 PMCID: PMC9516568 DOI: 10.3389/fvets.2022.1004841
Source DB: PubMed Journal: Front Vet Sci ISSN: 2297-1769
Components and nutritional composition of the basal TMR ration.
|
|
| ||
|---|---|---|---|
| Rice straw | 310 | NEm, Mcal/kg DM | 1.33 |
| Alfalfa hay | 190 | OM | 891.3 |
| Corn meal | 340 | CP | 73.9 |
| Soybean meal | 95 | EE | 18.6 |
| Wheat bran | 20 | NDF | 310.9 |
| Premix | 45 | ADF | 150.8 |
| Ca | 12.3 | ||
| P | 2.9 | ||
Every 1 kg of premix contained 2,800 mg of Zn, 2,200 mg of Mn, 1,500 mg of Fe, 980 mg of Cu, 36 mg of I, 16 mg of Co, 15 mg of Se, 2,400 mg of vitamin B3, 520000 IU of vitamin A, 160000 IU of vitamin D3, 1600 IU of vitamin E.
NEm, net energy for maintenance.
Effects of tannic acid at different doses on growth performance and apparent nutrient digestibility of black goats.
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| ||
| Growth performance | ||||||||
| DMI, kg/d | 0.74 | 0.71 | 0.76 | 0.69 | 0.124 | 0.331 | 0.463 | 0.627 |
| ADG, kg/d | 0.12 | 0.12 | 0.13 | 0.12 | 0.021 | 0.360 | 0.703 | 0.847 |
| FCR | 5.99 | 6.24 | 6.04 | 5.92 | 1.087 | 0.837 | 0.722 | 0.726 |
| Apparent nutrient digestibility, % | ||||||||
| DM | 66.36 | 67.83 | 63.97 | 64.34 | 2.834 | 0.287 | 0.168 | 0.383 |
| OM | 70.86 | 73.17 | 68.52 | 69.64 | 2.598 | 0.083 | 0.199 | 0.420 |
| CP | 70.82 | 67.19 | 55.33 | 52.00 | 8.006 | 0.044 | 0.004 | 0.020 |
| EE | 67.68 | 72.84 | 63.93 | 70.49 | 5.773 | 0.756 | 0.986 | 0.993 |
| NDF | 57.36 | 53.86 | 54.99 | 49.53 | 4.033 | 0.364 | 0.104 | 0.270 |
| ADF | 48.91 | 44.90 | 49.05 | 35.56 | 7.472 | 0.054 | 0.055 | 0.079 |
FCR, feed conversion ratio.
CON, control group; TAL, low-dose tannic acid treatment; TAM, mid-dose tannic acid treatment; TAH, high-dose tannic acid treatment.
SEM, standard error of means for treatments.
L, linear effect of the tannic acid dose; Q, quadratic effect of the tannic acid dose.
Means within a row for treatments that do not have a common superscript differ (P < 0.05).
Effects of tannic acid at different doses on rumen fermentation characteristics of black goats.
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| ||
| pH | 6.82 | 6.89 | 6.79 | 6.84 | 0.121 | 0.597 | 0.983 | 0.965 |
| NH3-N | 8.33 | 8.00 | 7.87 | 7.66 | 0.392 | 0.021 | 0.002 | 0.008 |
| TVFA | 28.48 | 29.02 | 69.07 | 68.17 | 21.929 | <0.001 | <0.001 | <0.001 |
| VFA profile (mol/100 mol) | ||||||||
| Acetate | 63.55 | 57.54 | 60.71 | 62.11 | 4.465 | 0.120 | 0.894 | 0.136 |
| Propionate | 19.22 | 19.56 | 18.15 | 19.71 | 2.249 | 0.670 | 0.987 | 0.824 |
| Butyrate | 9.87 | 12.62 | 11.07 | 10.35 | 2.379 | 0.225 | 0.982 | 0.222 |
| Isobutyrate | 2.87 | 3.81 | 3.51 | 2.93 | 0.807 | 0.131 | 0.941 | 0.071 |
| Valerate | 0.85 | 1.50 | 1.82 | 1.34 | 0.595 | 0.034 | 0.108 | 0.013 |
| Isovalerate | 3.65 | 4.97 | 4.74 | 3.57 | 1.271 | 0.124 | 0.841 | 0.054 |
| A:P | 3.42 | 2.96 | 3.35 | 3.20 | 0.519 | 0.462 | 0.779 | 0.760 |
TVFA, total volatile fatty acid; A:P, the ratio of acetate to propionate.
CON, control group; TAL, low-dose tannic acid treatment; TAM, mid-dose tannic acid treatment; TAH, high-dose tannic acid treatment.
SEM, standard error of means for treatments.
L, linear effect of the tannic acid dose; Q, quadratic effect of the tannic acid dose.
Means within a row for treatments that do not have a common superscript differ (P < 0.05).
Effects of tannic acid at different doses on biochemical and physiological parameters in the blood serum of black goats.
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| ||
| TP, g/L | 66.3 | 71.7 | 72.2 | 70.5 | 6.86 | 0.477 | 0.319 | 0.285 |
| ALB, g/L | 36.7 | 34.8 | 36.1 | 37.6 | 3.33 | 0.563 | 0.539 | 0.402 |
| GLB, g/L | 16.5 | 13.1 | 15.0 | 13.7 | 1.91 | 0.006 | 0.061 | 0.070 |
| IgA, g/L | 0.12 | 0.13 | 0.11 | 0.12 | 0.047 | 0.875 | 0.759 | 0.948 |
| IgG, g/L | 5.72 | 3.44d | 4.87 | 4.13 | 0.948 | <0.001 | 0.056 | 0.018 |
| CHE, U/L | 98.5 | 101.2 | 100.4 | 56.5 | 28.93 | 0.010 | 0.015 | 0.004 |
| GR, U/L | 15.5 | 14.7 | 13.7 | 8.0 | 3.41 | <0.001 | <0.001 | <0.001 |
| ALT, U/L | 3.74 | 4.12 | 6.67 | 4.60 | 1.562 | 0.002 | 0.077 | 0.028 |
| AST, U/L | 10.8 | 13.6 | 13.0 | 13.1 | 2.65 | 0.292 | 0.191 | 0.211 |
| CRE, μmol/L | 95.2 | 98.4 | 76.4 | 71.0 | 17.21 | 0.005 | 0.001 | 0.005 |
| BUN, mmol/L | 8.10 | 8.19 | 8.00 | 7.05 | 1.261 | 0.407 | 0.159 | 0.230 |
| GLU, mmol/L | 7.10 | 7.29 | 7.13 | 8.85 | 2.303 | 0.540 | 0.245 | 0.378 |
| TG, mmol/L | 0.11 | 0.17 | 0.21 | 0.20 | 0.055 | 0.002 | 0.001 | 0.001 |
| TC, mmol/L | 2.77 | 2.98 | 3.13 | 3.03 | 0.359 | 0.410 | 0.173 | 0.238 |
| HDLC, mmol/L | 0.92 | 0.68 | 0.60 | 0.78 | 0.185 | 0.009 | 0.132 | 0.003 |
| LDLC, mmol/L | 1.46 | 1.39 | 1.67 | 1.48 | 0.272 | 0.342 | 0.512 | 0.722 |
| HL, ng/mL | 95.7 | 92.4 | 104.0 | 101.8 | 23.23 | 0.839 | 0.501 | 0.801 |
| GH, ng/mL | 4.79 | 2.99 | 3.85 | 4.41 | 0.987 | 0.005 | 0.875 | 0.010 |
| T3, ng/mL | 6.77 | 5.63 | 6.49 | 5.70 | 1.341 | 0.397 | 0.358 | 0.634 |
| T4, ng/mL | 171.5 | 161.3 | 200.6 | 173.8 | 32.48 | 0.205 | 0.457 | 0.638 |
| CORT, μg/mL | 30.31 | 39.82 | 31.31 | 31.91 | 5.083 | 0.001 | 0.704 | 0.097 |
| EPI, ng/mL | 1.59 | 1.96 | 1.63 | 1.59 | 0.302 | 0.110 | 0.595 | 0.254 |
| INS, mU/L | 28.5 | 28.5 | 29.3 | 26.6 | 6.84 | 0.935 | 0.712 | 0.843 |
| GC, ng/mL | 0.23 | 0.29 | 0.26 | 0.25 | 0.048 | 0.262 | 0.817 | 0.288 |
| IGF-1, ng/mL | 248.3 | 168.3 | 198.2 | 197.9 | 44.47 | 0.011 | 0.147 | 0.026 |
| IGF-2, ng/mL | 14.81 | 13.31 | 11.91 | 13.50 | 4.092 | 0.722 | 0.498 | 0.542 |
| T-AOC, mmol/L | 0.26 | 0.26 | 0.31 | 0.29 | 0.035 | 0.014 | 0.041 | 0.064 |
| MDA, nmol/L | 3.76 | 4.32 | 3.30 | 3.21 | 0.965 | 0.186 | 0.140 | 0.248 |
| SOD, U/mL | 152.6 | 154.2 | 151.6 | 149.1 | 6.85 | 0.675 | 0.319 | 0.483 |
TP, total protein; ALB, albumin; GLB, globulin; IgA, immunoglobulin A; IgG, immunoglobulin G; CHE, cholinesterase; GR, glutathione reductase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRE, creatinine; BUN, blood urea nitrogen; GLU, glucose; TG, triglyceride; TC, total cholesterol; HDLC, high-density lipoprotein cholesterol; LDLC, low-density lipoprotein cholesterol; HL, hepatic lipase; GH, growth hormone; T3, triiodothyronine; T4, thyroxine; CORT, cortisol; EPI, epinephrine; INS, insulin; GC, glucagon; IGF-1, insulin-like growth factor 1; IGF-2, insulin-like growth factor 2; T-AOC, total antioxidant capacity; MDA, malondialdehyde; SOD, superoxide dismutase.
CON, control group; TAL, low-dose tannic acid treatment; TAM, mid-dose tannic acid treatment; TAH, high-dose tannic acid treatment.
SEM, standard error of means for treatments.
L, linear effect of the tannic acid dose; Q, quadratic effect of the tannic acid dose.
Means within a row for treatments that do not have a common superscript differ (P < 0.05).
Effects of tannic acid at different doses on lipopolysaccharide endotoxin in the rumen liquid and plasma, and relevant inflammatory indicators in the serum of black goats.
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| ||
| LPS-R, EU/mL | 17,134 | 18,409 | 20,040 | 19,056 | 2,128.8 | 0.123 | 0.061 | 0.072 |
| LPS-P, EU/mL | 5,558 | 5,457 | 5,443 | 6,062 | 607.4 | 0.272 | 0.193 | 0.153 |
| LBP, ng/mL | 128.5 | 115.2 | 134.9 | 128.0 | 33.00 | 0.806 | 0.7744 | 0.937 |
| IL-1β, pg/mL | 58.5 | 97.1 | 72.4 | 77.4 | 18.35 | 0.001 | 0.360 | 0.050 |
| IL-2, pg/mL | 973.6 | 1,011.1 | 958.9 | 917.2 | 161.16 | 0.823 | 0.474 | 0.661 |
| IL-6, pg/mL | 75.7 | 106.4 | 81.5 | 86.3 | 18.97 | 0.024 | 0.855 | 0.268 |
| IL-8, pg/mL | 127.1 | 144.4 | 139.7 | 161.5 | 32.85 | 0.374 | 0.109 | 0.281 |
| TNF-α, ng/mL | 115.2 | 140.6 | 116.1 | 121.8 | 21.71 | 0.161 | 0.914 | 0.570 |
| IFN-γ, pg/mL | 579.7 | 648.8 | 607.8 | 557.3 | 87.15 | 0.332 | 0.517 | 0.213 |
| Hp, ng/mL | 418.7 | 514.7 | 453.9 | 499.1 | 87.31 | 0.235 | 0.277 | 0.443 |
| SAA, ng/mL | 2947 | 4185 | 4120 | 3418 | 816.7 | 0.016 | 0.388 | 0.006 |
LPS-R, lipopolysaccharide in rumen liquid; LPS-P, lipopolysaccharide in plasma; LBP, lipopolysaccharide binding protein; IL-1β, interleukin-1β; IL-2, interleukin-2; IL-6, interleukin-6; IL-8, interleukin-8; TNF-α, tumor necrosis factor alpha; IFN-γ, interferon gamma; Hp, haptoglobin; SAA, serumamyloid A.
CON, control group; TAL, low-dose tannic acid treatment; TAM, mid-dose tannic acid treatment; TAH, high-dose tannic acid treatment.
SEM, standard error of means for treatments.
L, linear effect of the tannic acid dose; Q, quadratic effect of the tannic acid dose.
Means within a row for treatments that do not have a common superscript differ (P < 0.05).
Effects of tannic acid at different doses on Alpha diversity indices of the bacterial community in the rumen fluid of black goats.
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| ||
| Ace | 204 | 219 | 241 | 222 | 36.3 | 0.401 | 0.265 | 0.287 |
| Chao 1 | 198 | 213 | 241 | 224 | 36.3 | 0.224 | 0.113 | 0.159 |
| Shannon | 4.95 | 4.95 | 5.25 | 4.93 | 0.646 | 0.825 | 0.836 | 0.827 |
| Simpson | 0.92 | 0.92 | 0.91 | 0.90 | 0.047 | 0.896 | 0.509 | 0.799 |
CON, control group; TAL, low-dose tannic acid treatment; TAM, mid-dose tannic acid treatment; TAH, high-dose tannic acid treatment.
SEM, standard error of means for treatments.
L, linear effect of the tannic acid dose; Q, quadratic effect of the tannic acid dose.
Figure 1The principal coordinate analysis (PCoA) plots on rumen bacterial community structure across treatments. (A) PCoA based on the weighted Unifrac matrix. (B) PCoA based on the unweighted Unifrac matrix.
Figure 2The LDA effect size (LEfSe) analysis of bacterial taxa across treatments. (A) Cladogram displays significantly enriched bacterial taxa (from the phylum to the species level). Red: taxa abundant in the TAL treatment. (B) Bar chart displays LDA scores across treatments. The LDA scores represented the difference in relative abundance with exponent fold change of 10 across treatments. Significant differences are defined as P < 0.05 and LDA score > 4.0.
Figure 3The top ten annotated KEGG pathways (at level 2) across treatments based on Tax4Fun function prediction.